Literature DB >> 2073898

Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies.

M Orholm1, W Holten-Andersen, J D Lundgren.   

Abstract

To assess whether a recently developed indirect immunofluorescent stain using monoclonal antibodies was more sensitive in detecting Pneumocystis carinii than the combination of Giemsa and methenamine silver nitrate stains which has routinely been used in the laboratory, 88 lavage fluid specimens and 34 induced sputum specimens were examined. All specimens were stained by five techniques: immunofluorescence using a combination of three monoclonal antibodies (from the National Institutes of Health, USA), immunofluorescence using a single monoclonal antibody (from Dakopatts), Giemsa, methenamine silver nitrate and toluidine blue O. Immunofluorescence using the monoclonal antibodies from the NIH was significantly more sensitive than any other single staining method and than the combination of Giemsa and methenamine silver nitrate staining. The study also showed that the cytospin centrifuge was very suitable for the preparation of slides with lavage fluid and processed induced sputum. Finally, the sensitivity of examination of induced sputum to detect Pneumocystis carinii was found to be 50% when compared with bronchoalveolar lavage fluid. However, this sensitivity may increase through practice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073898     DOI: 10.1007/BF01967503

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

2.  Indication for fiberoptic bronchoscopy in HIV-infected patients suspected for Pneumocystis carinii pneumonia.

Authors:  M Orholm; J D Lundgren; T L Nielsen; J Iversen
Journal:  Dan Med Bull       Date:  1990-02

3.  Diagnosis of Pneumocystis carinii pneumonia by induced sputum in a city with moderate incidence of AIDS.

Authors:  R F O'Brien; J L Quinn; B T Miyahara; R B Lepoff; D L Cohn
Journal:  Chest       Date:  1989-01       Impact factor: 9.410

4.  Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies.

Authors:  K M Elvin; A Björkman; E Linder; N Heurlin; A Hjerpe
Journal:  BMJ       Date:  1988-08-06

5.  Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome.

Authors:  J A Golden; H Hollander; M S Stulbarg; G Gamsu
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

6.  Sputum induction for diagnosis of Pneumocystis carinii pneumonia.

Authors:  T R Leigh; P Parsons; C Hume; O A Husain; B Gazzard; J V Collins
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

7.  The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage.

Authors:  F P Ognibene; J Shelhamer; V Gill; A M Macher; D Loew; M M Parker; E Gelmann; A S Fauci; J E Parrillo; H Masur
Journal:  Am Rev Respir Dis       Date:  1984-06

8.  Value of bronchoalveolar lavage in the diagnosis of pulmonary infection in acquired immune deficiency syndrome.

Authors:  M Orenstein; C A Webber; M Cash; A E Heurich
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

9.  Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia.

Authors:  L L Gosey; R M Howard; F G Witebsky; F P Ognibene; T C Wu; V J Gill; J D MacLowry
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

10.  Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V Gill; J C Swan; F Ognibene; J Shelhamer; J E Parrillo; H Masur
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  4 in total

1.  Application and staining patterns of commercial anti-Pneumocystis carinii monoclonal antibodies.

Authors:  K Elvin; E Linder
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

3.  The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis.

Authors:  Conrad E Chan; Sebastian Götze; Geok T Seah; Peter H Seeberger; Nestan Tukvadze; Markus R Wenk; Brendon J Hanson; Paul A MacAry
Journal:  Sci Rep       Date:  2015-05-15       Impact factor: 4.379

Review 4.  Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.

Authors:  Evin Sowden; Andrew J Carmichael
Journal:  BMC Infect Dis       Date:  2004-10-16       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.